Antibiotic resistance (ABR) poses a threat to public health in the United States (US). The Centers for Disease Control and Prevention has identified three ABR urgent threats (defined as potential clinical and economic impact, transmissibility, available treatment, barriers to prevention): Clostridium difficile (C. diff), carbapenem-resistent Enterobacteriaceae (CRE), and Neisseria gonorrhoeae (N. gonorrhoeae). Limited data exist which document ABR-related burden in the context of inpatient care.
Article